Stem cell treatment for sexual function problems in perimenopausal women
Part of Women’s health & pregnancy clinical trials.
This Phase 2 study tests an injected stem cell treatment made from body fat to improve sexual function in women who are in the perimenopause stage (not yet fully through menopause). You may qualify if your hormone and symptom levels suggest decline and you meet general health and infection-safety checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman age 40–50 or older and not fully through menopause
- Have had a period within the last 2 months (and not for 12 months continuously)
- Recent hormone tests should show FSH above 40 and estradiol below 30 during days 2–4 of your cycle
- Have a sexual function score (FSFI) below 26.55 based on study questionnaires
- Have normal liver, kidney, and heart/blood vessel function based on blood tests and screening
- No current infections like HIV, hepatitis B (HBV), hepatitis C (HCV), or syphilis; you must also be able to give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether umbilical cord stem cells can improve hormone-related sexual function in men with low testosterone and related symptoms. It’s an early-phase study, so the goal is to see safety and whether symptoms and hormone measures improve.
This trial tests whether injecting stem cells or their byproducts can help men with erectile dysfunction who haven't responded well to standard treatments like Viagra. It aims to find a new option for improving sexual function.
This trial tests whether a single injection of stem cells from donated fat tissue can help women over 50 with stress urinary incontinence. It is for those who haven't gotten better with exercises or who want to avoid surgery.
This study tests a regenerative stem cell therapy to improve fertility in men with testicular failure or low sperm count and women with early ovarian failure. It is for people who have already tried standard treatments without success.
This trial tests if stem cells can help restore erectile function in men who have had prostate cancer surgery (RALP). It is for men with localized, low-risk cancer and good sexual function before surgery.
This trial tests whether a single infusion of stem cells made from human umbilical cord tissue can help women with premature ovarian insufficiency (early menopause) by improving ovarian function and reducing menopause symptoms. Participants will continue their usual hormone replacement therapy during the study.
Hear when a new Sexual Dysfunction Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.